Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ECM2 |
| Upstream (Parents) |
|---|
| (<<) SERPINF1 → ECM2 |
| (<<) IL1R1 → ECM2 |
| Downstream (Children) |
|---|
| ECM2 → TENC1 (>>) |
| ECM2 → LOC652637///WHAMML1 (>>) |
| ECM2 → DAAM2 (>>) |
| ECM2 → CADPS2 (>>) |
| ECM2 → TPD52 (>>) |
| ECM2 → PDGFC (>>) |
| ECM2 → PALM (>>) |
| ECM2 → LRP1 (>>) |
| ECM2 → DIP2C (>>) |
| ECM2 → WISP2 (>>) |
| ECM2 → CYP26A1 (>>) |
| ECM2 → DPT (>>) |
| ECM2 → NLGN4X (>>) |
| ECM2 → PFKFB2 (>>) |
| ECM2 → OLFML3 (>>) |
| ECM2 → TNXB///TNXA (>>) |
| ECM2 → CDK14 (>>) |
| ECM2 → GNG11 (>>) |
| ECM2 → OLFML1 (>>) |
| ECM2 → FAT4 (>>) |
| ECM2 → COPZ2 (>>) |
| ECM2 → HTRA1 (>>) |
| ECM2 → SETBP1 (>>) |
| ECM2 → NID1 (>>) |
